clinical trial – BIOENGINEER.ORG https://bioengineer.org Bioengineering Sat, 24 Jan 2026 18:11:07 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png clinical trial – BIOENGINEER.ORG https://bioengineer.org 32 32 72741379 NK Cell Infusion Shows Promise in Liver Cancer Trial https://bioengineer.org/nk-cell-infusion-shows-promise-in-liver-cancer-trial/ Sat, 24 Jan 2026 18:10:47 +0000 https://bioengineer.org/nk-cell-infusion-shows-promise-in-liver-cancer-trial/ 320397 Gait Training with Fisior® Improves Balance in Parkinson’s https://bioengineer.org/gait-training-with-fisior-improves-balance-in-parkinsons/ Tue, 20 Jan 2026 04:44:33 +0000 https://bioengineer.org/gait-training-with-fisior-improves-balance-in-parkinsons/ 318728 Tiprelestat: Breakthrough in Hospitalized COVID-19 Treatment https://bioengineer.org/tiprelestat-breakthrough-in-hospitalized-covid-19-treatment/ Mon, 19 Jan 2026 18:31:16 +0000 https://bioengineer.org/tiprelestat-breakthrough-in-hospitalized-covid-19-treatment/ 318499 Emory University and Micron Biomedical Initiate First Human Clinical Trial for Innovative Rotavirus Vaccine Utilizing Dissolvable Microarray Technology https://bioengineer.org/emory-university-and-micron-biomedical-initiate-first-human-clinical-trial-for-innovative-rotavirus-vaccine-utilizing-dissolvable-microarray-technology/ Tue, 17 Jun 2025 00:54:46 +0000 https://bioengineer.org/emory-university-and-micron-biomedical-initiate-first-human-clinical-trial-for-innovative-rotavirus-vaccine-utilizing-dissolvable-microarray-technology/ 249538 Study Reveals Blood Cancer Patients on Bruton Tyrosine Kinase Inhibitors Can Safely Continue Treatment During COVID-19 Vaccination https://bioengineer.org/study-reveals-blood-cancer-patients-on-bruton-tyrosine-kinase-inhibitors-can-safely-continue-treatment-during-covid-19-vaccination/ Tue, 01 Apr 2025 18:18:49 +0000 https://bioengineer.org/study-reveals-blood-cancer-patients-on-bruton-tyrosine-kinase-inhibitors-can-safely-continue-treatment-during-covid-19-vaccination/ 239720 Chemo-Immunotherapy Exhibits Promising Efficacy in Advanced HPV-Negative Head and Neck Cancer Patients https://bioengineer.org/chemo-immunotherapy-exhibits-promising-efficacy-in-advanced-hpv-negative-head-and-neck-cancer-patients/ Thu, 06 Mar 2025 21:31:35 +0000 https://bioengineer.org/chemo-immunotherapy-exhibits-promising-efficacy-in-advanced-hpv-negative-head-and-neck-cancer-patients/ 237802 Three years younger in just eight weeks? A new study suggests yes! https://bioengineer.org/three-years-younger-in-just-eight-weeks-a-new-study-suggests-yes/ https://bioengineer.org/three-years-younger-in-just-eight-weeks-a-new-study-suggests-yes/#respond Thu, 27 May 2021 18:42:17 +0000 https://bioengineer.org/three-years-younger-in-just-eight-weeks-a-new-study-suggests-yes/ https://bioengineer.org/three-years-younger-in-just-eight-weeks-a-new-study-suggests-yes/feed/ 0 170381